Refine by
Bronchoscopes Articles & Analysis: Older
10 news found
“The Zephyr Valve is a breakthrough technology because it is the first bronchoscopic procedure option that can provide significant improvements to patients with no improvement in their symptoms despite optimal medical therapy,” stated Prof. ...
The Galaxy System is designed to provide a fully integrated solution for robotic navigated bronchoscopy, which can help to improve the location accuracy and diagnosis of lung nodules using its proprietary TiLT+ Technology™. With its single use bronchoscope and small footprint, it is also designed to improve efficiency and reduce cross contamination. ...
The AeriSeal System is used to close collateral air channels in a target lung lobe of a patient with severe COPD/emphysema, making the patient eligible to then undergo Bronchoscopic Lung Volume Reduction (BLVR) with Zephyr Valves. Patients whose lungs have untreated collateral ventilation (CV+) are currently ineligible for treatment with Zephyr Valves and have limited options ...
The platform received high marks from pulmonologists and surgeons at its debut in May at the American Thoracic Society (ATS 2022) annual meeting in San Francisco for features such as its TiLT+ Technology™ with integrated tomosynthesis and augmented fluoroscopy, unique single-use disposable bronchoscope, and the smallest footprint of any current lung navigation robot on the ...
208 patients enrolled in a prospective, randomized, controlled, multicenter, interventional trial Unyvero reduced the use of inappropriate antibiotic therapy by 45%, shortened inappropriate antibiotic therapy by 39 hours, and reduced overall antibiotic therapy duration by 22.5% Unyvero results combined with antibiotic stewardship are efficient and safe in decreasing time on inappropriate ...
The scaffold is temporary and, after a few months, is removed using a bronchoscope (a minimally invasive procedure, there is no second surgery in the chest), leaving behind a regenerated bronchus derived from the patient's own cells. ...
The company, founded by medical robotics entrepreneur Jian Zhang, will use these state-of-the-art facilities to pursue disruptive new medical robotics indications left unaddressed by current platforms. “We envision a world in which next generation medical robots help diagnose disease and treat patients early to ensure minimal hospital stays and quick recoveries,” said Zhang, Noah ...
The American Lung Association recently released its 2021 State of Lung Cancer report. Lung cancer is the leading cause of cancer deaths worldwide because the disease is often diagnosed at the late stages. Early diagnosis of lung nodules can help patients get treatment sooner and improve long-term survival rates. Auris is committed to fighting this deadly disease by helping physicians diagnose ...
The Monarch Platform was featured on the cover of the March-April 2019 issue of Oncology Issues. The journal, which is the official journal of the Association of Community Cancer Centers, was created for multidisciplinary oncology teams to provide information on a range of topics in cancer care. In the March-April issue of the journal, the Monarch Platform was featured in an article titled ...
” Auris Health’s revolutionary Monarch Platform, the first FDA-cleared robotic platform for diagnostic and therapeutic bronchoscopic procedures, is designed with clinician ease-of-use in mind, with a dedicated camera and instrument channel, allowing continuous vision without removal of the camera to pass instruments. ...